Royalty Pharma plc
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various bioph…
Biotechnology
US, New York [HQ]
Cash Flow Statements
7 Sheets · Starting from 2023In Million USD. Margins, Growth Rates In %
| Metric | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Operating Cash Flow (OCF) | 1,418.00 | 1,618.00 | 1,667.00 | 2,034.00 | 2,017.00 | 2,143.00 | 3,031.00 | |
| Operating Cash (Net) | 1,418.00 | 1,618.00 | 1,667.00 | 2,034.00 | 2,017.00 | 2,143.00 | 3,031.00 | |
| Accounts Receivable | -84.00 | 111.00 | 159.00 | - - | -29.00 | 31.00 | 1.00 | |
| Accounts Payable | - - | 1.00 | 6.00 | - - | -4.00 | 2.00 | 6.00 | |
|
Working Capital
|
- - | - - | - - | - - | - - | - - | - - | |
| Change | -1,475.00 | -1,562.00 | -1,673.00 | -1,884.00 | -16.00 | 32.00 | 3,206.00 | |
| Other WC | -1,475.00 | -1,563.00 | -1,673.00 | -1,883.00 | -11.00 | 30.00 | 3,199.00 | |
| Investing Activities | ||||||||
| Used Cash (Net) | -1,587.00 | 303.00 | -2,116.00 | -2,759.00 | -1,870.00 | -1,029.00 | -2,104.00 | |
| Capital Expenditure | -2,290.00 | 269.00 | -1,721.00 | 2,197.00 | - - | 2,041.00 | -2,115.00 | |
| Purchases of Investments | -2,300.00 | -422.00 | -2,363.00 | -3,937.00 | -3,593.00 | -2,565.00 | -12.00 | |
| Sale/Maturity of Investment | 600.00 | 750.00 | 524.00 | 1,203.00 | 1,776.00 | 1,545.00 | 25.00 | |
| Property, Plant, Equipment (P&PE) | -2,290.00 | 269.00 | -1,721.00 | 2,197.00 | - - | 2,041.00 | -2,115.00 | |
| Acquisitions (Net) | -2.00 | -24.00 | -27.00 | -40.00 | -34.00 | -9.00 | 12.00 | |
| Other Investing Activities | 115.00 | -269.00 | 1,471.00 | -2,182.00 | -18.00 | -2,041.00 | -14.00 | |
| Financing Activities | ||||||||
| Used Cash (Net) | -123.00 | -1,379.00 | -1,191.00 | -1,487.00 | -385.00 | -944.00 | -2,161.00 | |
| Debt Repayment | -193.00 | -294.00 | -294.00 | -11,210.00 | -1,259.00 | - - | -1,000.00 | |
| Dividends Paid | -735.00 | -814.00 | -739.00 | -397.00 | -285.00 | -333.00 | -358.00 | |
|
Common Stock
|
- - | - - | 8 | -9,982 | - - | - - | 303 | |
| Issued | - - | - - | 4.00 | 1,909.00 | - - | - - | -1.00 | |
| Repurchased | - - | - - | -4.00 | 11,891.00 | - - | - - | -304.00 | |
| Other Financing Activities | 804.00 | -270.00 | -158.00 | -706.00 | 1,929.00 | -611.00 | -496.00 | |
| Cash Balances | ||||||||
| Begin of Period | 1,674.00 | 1,381.00 | 1,924.00 | 246.00 | 1,008.00 | 1,541.00 | 1,710.00 | |
| End of Period | 1,381.00 | 1,924.00 | 283.00 | 1,009.00 | 1,541.00 | 1,710.00 | 477.00 | |
| Change | -292.00 | 542.00 | -1,640.00 | 763.00 | 532.00 | 169.00 | -1,233.00 | |
| Non-Cash Balances | ||||||||
| Depreciation and Amortization | 33.00 | 33.00 | 23.00 | 23.00 | 22.00 | 5.00 | - - | |
| Stock Based Compensation | - - | - - | - - | 5.00 | 2.00 | 2.00 | 2.00 | |
| Other | 1,517.00 | 1,629.00 | 855.00 | 2,122.00 | 2,289.00 | 1,873.00 | -1,312.00 | |
| Highlighted metrics | ||||||||
| Free Cash Flow (FCF) | -872.00 | 1,887.00 | -54.00 | 4,231.00 | 2,018.00 | 4,185.00 | 916.00 | |
| Cash Conversion Cycle (CCC) | - - | 79.00 | 3.00 | 2,684.00 | -78.00 | -502.00 | 110.00 | |
| Invested Capital | - - | - - | - - | - - | - - | - - | - - | |
|
Other Operating Inflows/Outflows
|
||||||||
| Forex Effect on Cash | - - | - - | - - | - - | - - | - - | - - |